World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 12 December 2020
Main ID:  NCT02042014
Date of registration: 17/01/2014
Prospective Registration: Yes
Primary sponsor: Novartis Pharmaceuticals
Public title: Open-label, Multi-center Protocol to Provide QTI571 to PAH Patients Who Participated in the Extension Study (A2301E1) in Japan
Scientific title: An Open-label, Multi-center Protocol to Provide QTI571 to PAH Patients Who Participated in the Extension Study (A2301E1) in Japan and Are Judged by the Investigator to Benefit From Continued QTI571 Treatment
Date of first enrolment: January 22, 2014
Target sample size: 8
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT02042014
Study type:  Interventional
Study design:  Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).  
Phase:  Phase 3
Countries of recruitment
Japan
Contacts
Key inclusion & exclusion criteria

Inclusion Criteria:

- patient is receiving QTI571 for the treatment of Pulmonary Arterial Hypertension (PAH)
and is currectly enrolled in a long-term extension study (CQTI571A2301E1) in Japan.

- Patient is currently benifitting form the treatment with QTI571 in the opinion of the
investigator.

Exclusion Criteria:

- Patient has been permanently discontinued from QTI571 study treatment in the parent
study.

- Concomitant use of oral vitamin K antagonist medication.



Age minimum: 18 Years
Age maximum: N/A
Gender: All
Health Condition(s) or Problem(s) studied
Severe Pulmonary Arterial Hypertension
Intervention(s)
Drug: QTI571
Primary Outcome(s)
Serious Adverse Events [Time Frame: Approximately 2.9 years]
Secondary Outcome(s)
Secondary ID(s)
CQTI571AJP01
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available: Yes
Date Posted: 18/06/2019
Date Completed:
URL: https://clinicaltrials.gov/ct2/show/results/NCT02042014
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history